| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-12 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |